REYON Pharmaceutical Co., Ltd. (KRX:102460)

REYON Pharmaceutical Revenue

REYON Pharmaceutical had revenue of 36.05B KRW in the quarter ending March 31, 2026, a decrease of -1.92%. This brings the company's revenue in the last twelve months to 145.22B, down -1.91% year-over-year. In the year 2025, REYON Pharmaceutical had annual revenue of 145.93B, down -1.60%.

• Revenue (ttm): 145.22B
• Revenue Growth: -1.91%
• P/S Ratio: 1.26
• Revenue / Employee: 330.05M
• Employees: 448
• Market Cap: 183.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	145.93B	-2.37B	-1.60%
Dec 31, 2024	148.30B	-2.77B	-1.83%
Dec 31, 2023	151.07B	-2.97B	-1.93%
Dec 31, 2022	154.04B	11.24B	7.87%
Dec 31, 2021	142.80B	12.77B	9.82%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error